DE602006020634D1 - Antikoagulans/antithrombose-dual-hemmer mit einem biotin-label - Google Patents

Antikoagulans/antithrombose-dual-hemmer mit einem biotin-label

Info

Publication number
DE602006020634D1
DE602006020634D1 DE602006020634T DE602006020634T DE602006020634D1 DE 602006020634 D1 DE602006020634 D1 DE 602006020634D1 DE 602006020634 T DE602006020634 T DE 602006020634T DE 602006020634 T DE602006020634 T DE 602006020634T DE 602006020634 D1 DE602006020634 D1 DE 602006020634D1
Authority
DE
Germany
Prior art keywords
oligosaccharide
residue
gpiib
spacer
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006020634T
Other languages
English (en)
Inventor
Kort Martin De
Boeckel Constant Adriaan Van
Charles David Nicholson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Publication of DE602006020634D1 publication Critical patent/DE602006020634D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
    • A61K47/665—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells the pre-targeting system, clearing therapy or rescue therapy involving biotin-(strept) avidin systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE602006020634T 2005-10-10 2006-10-06 Antikoagulans/antithrombose-dual-hemmer mit einem biotin-label Active DE602006020634D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05109403 2005-10-10
EP05109962 2005-10-25
PCT/EP2006/067127 WO2007042469A2 (en) 2005-10-10 2006-10-06 Anticoagulant antithrombotic dual inhibitors comprising a biotin label

Publications (1)

Publication Number Publication Date
DE602006020634D1 true DE602006020634D1 (de) 2011-04-21

Family

ID=37451080

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006020634T Active DE602006020634D1 (de) 2005-10-10 2006-10-06 Antikoagulans/antithrombose-dual-hemmer mit einem biotin-label

Country Status (17)

Country Link
EP (1) EP1991271B1 (de)
JP (1) JP5060486B2 (de)
KR (1) KR20080055960A (de)
AT (1) ATE500849T1 (de)
AU (1) AU2006301331B2 (de)
BR (1) BRPI0617215A2 (de)
CA (1) CA2624588C (de)
DE (1) DE602006020634D1 (de)
EC (1) ECSP088443A (de)
HR (1) HRP20110331T1 (de)
IL (1) IL190523A0 (de)
MY (1) MY145269A (de)
NO (1) NO20081619L (de)
NZ (1) NZ567221A (de)
PL (1) PL1991271T3 (de)
RU (1) RU2434876C2 (de)
WO (1) WO2007042469A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2233143A1 (de) * 2009-03-24 2010-09-29 Sanofi-Aventis Verwendung von Idrabiotaparinux zur Senkung der Blutungsinzidenz bei einer Thrombosebehandlung
EP2145624A1 (de) * 2008-07-18 2010-01-20 Sanofi-Aventis Verwendung von Idrabiotaparinux zur Senkung der Blutungsinzidenz bei einer Thrombosebehandlung
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
JP6109574B2 (ja) 2009-12-18 2017-04-05 カタラン、フランス、バインハイム、ソシエテ、アノニムＣａｔａｌｅｎｔ Ｆｒａｎｃｅ Ｂｅｉｎｈｅｉｍ Ｓａ 合成オリゴサッカリドを含有する医薬経口剤形
WO2012042123A1 (fr) * 2010-09-10 2012-04-05 Sanofi Polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree
EP2721044B1 (de) * 2011-06-17 2015-11-18 Carbomimetics Synthetische pentasaccharide mit kurzer halbwertszeit und hoher aktivität

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217869B1 (en) * 1992-06-09 2001-04-17 Neorx Corporation Pretargeting methods and compounds
TWI289566B (en) * 1999-12-07 2007-11-11 N.V.Organon Antithrombotic compound
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
EP1574516A1 (de) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotische Verbindungen

Also Published As

Publication number Publication date
ATE500849T1 (de) 2011-03-15
ECSP088443A (es) 2008-06-30
RU2434876C2 (ru) 2011-11-27
PL1991271T3 (pl) 2011-08-31
MY145269A (en) 2012-01-13
RU2008118365A (ru) 2009-11-20
JP5060486B2 (ja) 2012-10-31
WO2007042469A2 (en) 2007-04-19
BRPI0617215A2 (pt) 2011-07-19
WO2007042469A3 (en) 2007-11-29
CA2624588A1 (en) 2007-04-19
EP1991271B1 (de) 2011-03-09
AU2006301331B2 (en) 2011-12-22
EP1991271A2 (de) 2008-11-19
KR20080055960A (ko) 2008-06-19
NZ567221A (en) 2010-06-25
AU2006301331A1 (en) 2007-04-19
JP2009511543A (ja) 2009-03-19
HRP20110331T1 (hr) 2011-06-30
CA2624588C (en) 2014-05-20
IL190523A0 (en) 2008-11-03
NO20081619L (no) 2008-07-03

Similar Documents

Publication Publication Date Title
DE602006020634D1 (de) Antikoagulans/antithrombose-dual-hemmer mit einem biotin-label
WO2007042470A3 (en) Antithrombotic compound
BRPI0508461A (pt) diaminopirimidinas como antagonistas de p2x3 e p2x2/3
BRPI0507345A (pt) composto antitrombótico
UA94593C2 (ru) Антитромбозные двойные ингибиторы с биотиновой меткой
NO20074149L (no) Nye farmasoytiske sammensetninger for behandling av trombose
TW200606151A (en) Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
BRPI0606817A2 (pt) derivados de piridazina e seu uso como agentes terapêuticos
NO20063662L (no) Benzimidazolderivater
AR078082A1 (es) Composiciones farmaceuticas que comprenden fucanos modificados, metodos y kits relacionados
AU2008228162A1 (en) Low molecular weight heparins including at least one covalent bond with biotin or a biotin derivative, method for making same and use thereof
BRPI0511480A (pt) derivados de azaaçúcar, inibidores de herparanases, seu processo de preparação, as composições que os contêm, sua utilização
WO2007064620A3 (en) Compositions comprising a combination of ccr5 and cxcr4 antagonists
BR0313384A (pt) Derivados de cromona como inibidores de metaloproteinases de matriz
UA88793C2 (ru) Антитромботические двойные ингибиторы, которые содержат остаток биотина
JP2009511543A5 (de)
TW201030011A (en) Imidazothiazole derivatives bearing the proline ring structure
Wang et al. Synthesis and antibacterial activity of novel icariin derivatives
BR0213325A (pt) Derivados de 4-fenil-4-[1h-imidazol-2-il]-piperidina substituìda para a redução de dano isquêmico
NL2031742B1 (en) Pseudo-Disaccharide Compounds
BR0308807A (pt) Compostos tiazol-2-il-imina como inibidores de pde-7
AU2001233242B2 (en) Tosylproline analogs as thymidylate synthase inhibitors
MY144635A (en) 2-oxo-1,2,4,5-tetrahydro-1,-3-benzodiazepin-3-yl-piperidines used as cgrp antagonists
WO2007146323A3 (en) Substituted cyanopyridines as protein kinase inhibitors
MXPA05008190A (es) Derivado de oligosacarido.

Legal Events

Date Code Title Description
R082 Change of representative

Ref document number: 1991271

Country of ref document: EP

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE